141 related articles for article (PubMed ID: 35797305)
21. Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu District, Shanghai City, China, 2014-2019.
Li P; Liu Q; Li W; Liu Z; Xing B; Wu S; Zhou Z; Sun L; Ren H; Li H; Li H
Virol J; 2021 Mar; 18(1):51. PubMed ID: 33685499
[TBL] [Abstract][Full Text] [Related]
22. The prevalence, genotype distribution of human papillomavirus and cervical cytology in Wenzhou, China: a retrospective research of 7391 cases.
Lin Q; Lin X; Zhuang X; Tang Y; Zhao Z
Diagn Cytopathol; 2021 Feb; 49(2):211-218. PubMed ID: 32965784
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
[TBL] [Abstract][Full Text] [Related]
24. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
25. Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions.
Bello BD; Spinillo A; Alberizzi P; Cesari S; Gardella B; D'Ambrosio G; Roccio M; Silini EM
J Med Virol; 2009 Apr; 81(4):703-12. PubMed ID: 19235847
[TBL] [Abstract][Full Text] [Related]
26. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
27. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
28. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
[TBL] [Abstract][Full Text] [Related]
29. Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31-65.
Dickson EL; Vogel RI; Geller MA; Downs LS
Gynecol Oncol; 2014 Jun; 133(3):405-8. PubMed ID: 24657488
[TBL] [Abstract][Full Text] [Related]
30. [Chlamydia trachomatis and human papillomavirus (HPV) infections in teenage sexually active girls].
Friedek D; Ekiel A; Romanik M; Chełmicki Z; Chełmicki A; Martirosian G
Ginekol Pol; 2005 Nov; 76(11):879-83. PubMed ID: 16566362
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study.
Waisberg MG; Ribeiro AC; Candido WM; Medeiros PB; Matsuzaki CN; Beldi MC; Tacla M; Caiaffa-Filho HH; Bonfa E; Silva CA
Rheumatol Int; 2015 Mar; 35(3):459-63. PubMed ID: 25348220
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
33. Analysis of HPV distribution in patients with cervical precancerous lesions in Western China.
Li K; Yin R; Li Q; Wang D
Medicine (Baltimore); 2017 Jul; 96(29):e7304. PubMed ID: 28723743
[TBL] [Abstract][Full Text] [Related]
34. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
35. Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women.
Ngamkham J; Boonmark K; Phansri T
Asian Pac J Cancer Prev; 2016; 17(3):1129-34. PubMed ID: 27039737
[TBL] [Abstract][Full Text] [Related]
36. [Cervical dysplasia and microflora of sexual tract].
Friedek D; Ekiel A; Wiechuła B; Chełmicki Z; Romanik M; Martirosian G
Med Dosw Mikrobiol; 2007; 59(3):267-73. PubMed ID: 18078122
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
38. HPV viral activity by mRNA-HPV molecular analysis to screen the transforming infections in precancer cervical lesions.
Tinelli A; Leo G; Pisanò M; Storelli F; Leo S; Vergara D; Malvasi A
Curr Pharm Biotechnol; 2009 Dec; 10(8):767-71. PubMed ID: 19912106
[TBL] [Abstract][Full Text] [Related]
39. Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina.
Deluca GD; Basiletti J; Schelover E; Vásquez ND; Alonso JM; Marín HM; Lucero RH; Picconi MA
Braz J Infect Dis; 2011; 15(6):567-72. PubMed ID: 22218516
[TBL] [Abstract][Full Text] [Related]
40. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
Monsonego J; Bohbot JM; Pollini G; Krawec C; Vincent C; Merignargues I; Haroun F; Sednaoui P; Monfort L; Dachez R; Syrjänen K
Gynecol Oncol; 2005 Oct; 99(1):160-8. PubMed ID: 16023184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
